349 related articles for article (PubMed ID: 3916502)
1. Improved immunosuppression for heart transplantation.
Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE
J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
[TBL] [Abstract][Full Text] [Related]
2. The Stanford experience: survival and renal function in the pre-sandimmune era compared to the sandimmune era.
Hunt SA; Gamberg P; Stinson EB; Oyer PE; Shumway NE
Transplant Proc; 1990 Jun; 22(3 Suppl 1):1-5. PubMed ID: 2349732
[No Abstract] [Full Text] [Related]
3. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
[TBL] [Abstract][Full Text] [Related]
4. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
5. Reduction of infectious complications following heart transplantation with triple-drug immunotherapy.
Andreone PA; Olivari MT; Elick B; Arentzen CE; Sibley RK; Bolman RM; Simmons RL; Ring WS
J Heart Transplant; 1986; 5(1):13-9. PubMed ID: 3302153
[TBL] [Abstract][Full Text] [Related]
6. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
[No Abstract] [Full Text] [Related]
7. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
8. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
Olivari MT; Antolick A; Ring WS
J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
[TBL] [Abstract][Full Text] [Related]
9. [The effect of cyclosporin on renal function following cardiac transplantation: should one lessen the toxicity?].
Carrier M; Pelletier GB; Leclerc Y; Castonguay YR; Solymoss BC; Pelletier LC
Can J Surg; 1990 Jun; 33(3):243-7. PubMed ID: 2350751
[TBL] [Abstract][Full Text] [Related]
10. Improved early course after cadaveric renal transplantation by reducing the cyclosporine dose and adding azathioprine.
Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin I; Gäbel H; Persson H; Groth CG
Transplant Proc; 1987 Feb; 19(1 Pt 3):2074-9. PubMed ID: 3547910
[No Abstract] [Full Text] [Related]
11. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
[No Abstract] [Full Text] [Related]
12. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
13. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J
Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
[No Abstract] [Full Text] [Related]
14. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
[No Abstract] [Full Text] [Related]
15. Management of cyclosporine toxicity by reduced dosage and azathioprine.
Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
[TBL] [Abstract][Full Text] [Related]
16. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
[TBL] [Abstract][Full Text] [Related]
17. [Results of the initial 50 heart transplantations in Zurich].
Schneider K; Siebenmann R; von Segesser L; Laske A; Gallino A; Mohacsi P; Leonardi A; Schmid ER; Schneider J; Turina M
Schweiz Med Wochenschr; 1989 Oct; 119(43):1524-9. PubMed ID: 2609128
[TBL] [Abstract][Full Text] [Related]
18. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
[No Abstract] [Full Text] [Related]
19. Immunosuppression in cardiac transplantation.
Rose EA; Addonizio LJ
Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
[No Abstract] [Full Text] [Related]
20. Self-reported change in physical symptoms from cyclosporine-based therapy to azathioprine-based therapy in heart transplant recipients.
Lough ME; Miller JL; Gamberg P
J Heart Transplant; 1986; 5(4):322-6. PubMed ID: 3305825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
